16.980
16.98 (0%)
As of Dec 20, 2024
Uniqure N.V. [QURE]
Source:
Company Overview
Uniqure N.v.are a leader in the field of gene therapy and seek to deliver to patients suffering from rare and other devastating diseases single treatments with potentially curative results. We are advancing a pipeline of innovative gene therapies, including our clinical candidate for the treatment of Huntington’s disease and amyotrophic lateral sclerosis as well as preclinical product candidates, including candidates for the treatment of refractory temporal lobe epilepsy and Fabry disease.
Country | United States |
Headquarters | amsterdam |
Phone Number | 1-339-970-7000 |
Industry | manufacturing |
CEO | Matthew Kapusta |
Website | www.uniqure.com |